Agent for the prevention or treatment of postmenopausal osteoporosis as an active ingredient herb plant

• 1. 苦参碱衍生物在制备预防或治疗绝经后骨质疏松症药物中的应用 [P] . 中国专利： CN106619628B . 2019.11.15
• 2. 乳果糖在预防或治疗绝经后骨质疏松症的应用 [P] . 中国专利： CN109846893A . 2019-06-07
• 3. AGENT FOR PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS CONTAINING HERB PLANT AS ACTIVE COMPONENT [P] . 日本专利： JP2000053576A . 2000-02-22

  机译： 预防和治疗以草药为有效成分的绝经后骨质疏松症治疗剂

• 4. SOIL TREATMENT AGENT OR SEED TREATMENT AGENT UNDERSTANDING QUINOLINE COMPOUNDS OR SALTS OF THESE AS ACTIVE INGREDIENT, OR METHOD FOR PREVENTION OF PLANT DISEASES THROUGH THEIR USE. [P] . BRPI0718929A2 . 2014-07-08

  机译： 理解喹啉化合物或盐作为有效成分的土壤处理剂或种子处理剂，或通过使用防止植物病害的方法。

• 5. 4- Composition for the treatment or prevention of postmenopausal obesity in women comprising 4-hexylresorcinol as an active ingredient [P] . KR20210119930A . 2021-10-06

  机译： 4-用于治疗或预防含有4-己基霉酚作为活性成分的妇女绝经后肥胖的组合物

• 1. Intestinal microbiota:a potential target for the treatment of postmenopausal osteoporosis [J] . Xin Xu, Xiaoyue Jia, Longyi Mo, 骨研究（英文版） . 2017,第003期
• 2. Intestinal microbiota＂ a potential target for the treatment of postmenopausal osteoporosis [J] . Xin Xu, Xiaoyue Jia, Longyi Mo, 骨研究：英文 . 2017,第003期
• 3. The clinical value of BALP on diagnosis and treatment of osteoporosis in postmenopausal women [J] . Weiguo Li, Hua Lin, Yong Qiu, 生物医学研究杂志（英文版） . 2006,第006期
• 4. Role of Optimized Plant Protein Combinations as a Low-Cost Alternative to Dairy Ingredients in Foods for Prevention and Treatment of Moderate Acute Malnutrition and Severe Acute Malnutrition [C] . Mark Manary, Meghan Callaghan-Gillespie Nestlé Nutrition Workshop . 2020
• 5. In-vivo studies of fullerene-bis(bisphosphonate) and synthesis of a fullerene-bisphosphonate-beta-blocker conjugate for the prevention and treatment of osteoporosis. [D] . Peralta, Ivana Romina Guadalupe. 2010
• 6. A Network Pharmacology Approach to Estimate the Active Ingredients and Potential Targets of Cuscutae semen in the Treatment of Osteoporosis [O] . Weiran Dai, Yue Sun, Guoqiang Zhong 2020
• 7. PMS15 Mixed Treatment Comparison to Rank Antiresorptive Agents In Preventing New Non Vertebral Fractures In Postmenopausal Osteoporosis [O] . Massafra U, Integlia D, Broccoli S, 2015
• 8. Development of Potent Orally Active Agents for Prevention and Treatment of Poxvirus Infection. [R] . Hostetler, K. Y. 2003

• 1. A network pharmacology approach to determine the active ingredients and potential targets of Chinese herb Juglans mandshurica Maxim. for treatment of lung cancer [J] . Yeqing Du1 ,Qiang Ren1 ,Zhiyang Yan1 . 亚洲传统医药 . 2019,第001期
• 2. Curative Effect Analysis of Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis with Different Bone Turnover Rates [J] . Suming Jie ,Jinmei Deng ,Caixia Lin . 临床医学国际期刊（英文） . 2018,第8期
• 3. 龟板诱导干细胞归巢预防绝经后骨质疏松症的机制探讨 [C] . 余翔 ,YU Xiang ,REN Hui . 第十届全国中医药博士生学术论坛 . 2019
• 4. 绝经后骨质疏松症的研究进展——附：用循证医学方法评价补肾益精法治疗绝经后骨质疏松症的临床疗效 [A] . 孙青凤 . 2005